The vice chancellor of Chennai's SRM University revealed that it will be commercializing its US patented herbal diabetic drug in the next six months.
Speaking to IANS, Vice Chancellor M. Ponnavaikko said: "We have incorporated a company called SRM Pharma Ltd. In another six months we may launch the drug. We can get the drug manufactured from a unit in north India."
Diabetes Screening
Diabetes screening is done using blood tests like fasting blood sugar and hemoglobin A1c levels. Diabetes affects 8.3% Americans and about 10% Indians.
Advertisement
Last December, the US Patent office granted patent for an herbal formulation for prevention and management of type-2 diabetes mellitus and vascular complications associated with the disease.
A six member team of researchers led by Govind Prasad Dubey and comprising Aruna Agrawal, Nirupama Dubey, Shipra Dubey, Rajesh Dubey and Samamtsan Mercy Deborah invented the drug and secured the patent which was assigned to SRM University, said Ponnavaikko.
![Type 2 Diabetes]( "Type 2 Diabetes")
Globalization and changing lifestyles has made diabetes very common in developing countries so much so that India is known as the Diabetes Capital of the World.
Type-II diabetes mellitus is a metabolic disorder that is primarily characterised by insulin resistance, relative insulin deficiency and hyperglycemia, states the background notes on the invention.
It is rapidly increasing in the developed countries and there is also evidence that this pattern will be followed in much of the rest of the parts of the world in coming years.
About 90-95 percent of all North Americans are suffering from type-II diabetes and 20 percent of the population are over the age of 65 years.
According to Ponnavaikko, the university has already filed two more inventions for patent with the US patent office.
"We will shortly file patent application for two more herbal drugs for menopause, cardiovascular and obesity problems," he said.
Source: IANS
Type 2 Diabetes
Globalization and changing lifestyles has made diabetes very common in developing countries so much so that India is known as the Diabetes Capital of the World.
Advertisement
Type-II diabetes mellitus is a metabolic disorder that is primarily characterised by insulin resistance, relative insulin deficiency and hyperglycemia, states the background notes on the invention.
It is rapidly increasing in the developed countries and there is also evidence that this pattern will be followed in much of the rest of the parts of the world in coming years.
About 90-95 percent of all North Americans are suffering from type-II diabetes and 20 percent of the population are over the age of 65 years.
According to Ponnavaikko, the university has already filed two more inventions for patent with the US patent office.
"We will shortly file patent application for two more herbal drugs for menopause, cardiovascular and obesity problems," he said.
Source: IANS
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Diabetes News
The rising incidence of type 2 diabetes among children underscores a significant and worrying health shift.
Engaging in smoking also heightens the likelihood of complications associated with diabetes, including cardiovascular disease, kidney failure, and blindness.
Recently compiled guidelines originating in Australia for foot diseases related to diabetes have been consolidated.
An expert emphasized the significance of protecting diabetic patients from the increasing levels of air pollution.
Factors such as dining out, industrialization, migration to urban areas, and other elements contribute to the heightened susceptibility of Indians to diabetes.